Published in Expert Opin Med Diagn on November 01, 2011
Identification of gene-environment interactions in cancer studies using penalization. Genomics (2013) 1.03
Racial differences in three major NHL subtypes: descriptive epidemiology. Cancer Epidemiol (2015) 0.87
Risk Factors of Follicular Lymphoma. Expert Opin Med Diagn (2012) 0.87
Integrative analysis of cancer prognosis data with multiple subtypes using regularized gradient descent. Genet Epidemiol (2012) 0.87
Integrative analysis of prognosis data on multiple cancer subtypes. Biometrics (2014) 0.80
Racial differences in mantle cell lymphoma in the United States. BMC Cancer (2014) 0.78
Prediagnostic plasma concentrations of organochlorines and risk of B-cell non-Hodgkin lymphoma in envirogenomarkers: a nested case-control study. Environ Health (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med (2002) 24.07
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med (1993) 17.71
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med (2002) 14.01
Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet (2007) 12.27
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood (2004) 11.07
A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell (2003) 6.11
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst (2005) 3.19
Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem (2001) 3.07
Gene and pathway-based second-wave analysis of genome-wide association studies. Eur J Hum Genet (2010) 3.03
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood (2001) 2.35
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood (2007) 2.31
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood (2003) 2.16
Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer (2008) 2.02
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med (1987) 1.94
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol (2004) 1.71
Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica (2006) 1.64
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood (2007) 1.63
Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci U S A (2003) 1.58
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58
Penalized feature selection and classification in bioinformatics. Brief Bioinform (2008) 1.51
Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer (2004) 1.50
HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood (2003) 1.47
Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol (2005) 1.42
p53 mutations are associated with histologic transformation of follicular lymphoma. Blood (1993) 1.40
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood (1998) 1.36
Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis (2006) 1.32
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood (2007) 1.30
Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet (2006) 1.24
Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol (2008) 1.23
Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr (2002) 1.22
A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst (2005) 1.20
Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun (2006) 1.20
Incorporating gene co-expression network in identification of cancer prognosis markers. BMC Bioinformatics (2010) 1.20
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant (2000) 1.19
Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood (2002) 1.18
Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer (2011) 1.16
Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia). Cancer Causes Control (2005) 1.16
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol (2008) 1.14
Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study. Occup Environ Med (2010) 1.13
Occupational exposures and non-Hodgkin's lymphoma in Southern Sweden. Int J Occup Environ Health (2004) 1.12
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer (2010) 1.12
Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst (1995) 1.11
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis (2008) 1.08
Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer (2001) 1.07
Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica (2007) 1.07
Nutrient intake and risk of non-Hodgkin's lymphoma. Am J Epidemiol (2006) 1.06
A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood (2008) 1.04
Occupational exposure to solvents and the risk of lymphomas. Epidemiology (2006) 1.02
Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival. Am J Hematol (2010) 1.01
Identification of non-Hodgkin's lymphoma prognosis signatures using the CTGDR method. Bioinformatics (2009) 1.01
Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men. Epidemiology (2010) 0.99
Historical review of lymphomas. Br J Haematol (2000) 0.99
Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol (2007) 0.99
Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms. Haematologica (2007) 0.98
Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. Semin Hematol (2000) 0.98
Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma. Genes Chromosomes Cancer (2007) 0.97
The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma. Int J Cancer (2008) 0.97
Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. Br J Haematol (2007) 0.97
Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes. Occup Environ Med (2007) 0.96
Increased risk of non-Hodgkin lymphoma and serum organochlorine concentrations among neighbors of a municipal solid waste incinerator. Environ Int (2010) 0.95
Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol (2007) 0.95
Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin's lymphoma: a population-based study. Ann Oncol (2006) 0.93
Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95. J Clin Oncol (2005) 0.93
Identification of predictive pathways for non-hodgkin lymphoma prognosis. Cancer Inform (2010) 0.93
Plasma organochlorine levels and risk of non-Hodgkin lymphoma in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev (2010) 0.92
Who is WHO and what was REAL? Swiss Med Wkly (2002) 0.91
Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Haematol (1999) 0.91
BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. Carcinogenesis (2007) 0.91
Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma. J Physiol Biochem (2004) 0.91
Incorporating higher-order representative features improves prediction in network-based cancer prognosis analysis. BMC Med Genomics (2011) 0.90
Ranking prognosis markers in cancer genomic studies. Brief Bioinform (2010) 0.90
The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma. Blood (2005) 0.89
Semiparametric prognosis models in genomic studies. Brief Bioinform (2010) 0.88
Effects of dietary folate, vitamin B12 and methionine/choline deficiency on immune function. Adv Exp Med Biol (1981) 0.87
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. Leuk Lymphoma (2007) 0.87
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma. Genes Immun (2007) 0.87
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival. Haematologica (2007) 0.86
Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States). Cancer Causes Control (2005) 0.84
Exposure to solvents and risk of non-Hodgkin lymphoma: clues on putative mechanisms. Cancer Epidemiol Biomarkers Prev (2007) 0.82
Alcohol consumption and non-Hodgkin lymphoma survival. J Cancer Surviv (2009) 0.82
Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells. Scand J Immunol (2003) 0.80
Impact of gene expression profiling in lymphoma diagnosis and prognosis. Histopathology (2011) 0.76
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control (2008) 3.72
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res (2009) 2.51
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Regularized estimation in the accelerated failure time model with high-dimensional covariates. Biometrics (2006) 2.30
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood (2006) 2.06
Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer (2008) 2.02
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis (2011) 1.81
In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol (2006) 1.81
Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol (2004) 1.65
Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. Radiology (2004) 1.65
A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid (2009) 1.62
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60
Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control (2004) 1.59
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58
Macrophage-specific expression of human lysosomal acid lipase corrects inflammation and pathogenic phenotypes in lal-/- mice. Am J Pathol (2006) 1.57
Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women. Leuk Lymphoma (2010) 1.55
Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study. Eur J Cancer Prev (2015) 1.54
Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2007) 1.53
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One (2009) 1.52
A Selective Review of Group Selection in High-Dimensional Models. Stat Sci (2012) 1.49
Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. Blood (2009) 1.48
Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev (2005) 1.47
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet (2006) 1.47
Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis (2004) 1.47
Variation in lung cancer risk by smoky coal subtype in Xuanwei, China. Int J Cancer (2008) 1.45
Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res (2009) 1.45
CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res (2010) 1.45
Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control (2008) 1.43
TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol (2004) 1.42
Coping with health care expenses among poor households: evidence from a rural commune in Vietnam. Soc Sci Med (2011) 1.42
The Sparse Laplacian Shrinkage Estimator for High-Dimensional Regression. Ann Stat (2011) 1.41
Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst (2004) 1.39
Oxygen vacancy induced band-gap narrowing and enhanced visible light photocatalytic activity of ZnO. ACS Appl Mater Interfaces (2012) 1.33
Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer (2005) 1.32
Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis (2006) 1.32
A semiparametric approach for the nonparametric transformation survival model with multiple covariates. Biostatistics (2006) 1.32
Semiparametric Regression Pursuit. Stat Sin (2012) 1.32
Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis (2008) 1.32
Principal component analysis based methods in bioinformatics studies. Brief Bioinform (2011) 1.31
Structural, electronic, and optical properties of oxygen defects in Zn3N2. J Phys Chem B (2007) 1.31
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat (2007) 1.30
Variable selection in the accelerated failure time model via the bridge method. Lifetime Data Anal (2009) 1.30
Do Polybrominated Diphenyl Ethers (PBDEs) Increase the Risk of Thyroid Cancer? Biosci Hypotheses (2008) 1.29
Health insurance coverage and impact: a survey in three cities in China. PLoS One (2012) 1.29
Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat (2010) 1.28
Coal use, stove improvement, and adult pneumonia mortality in Xuanwei, China: a retrospective cohort study. Environ Health Perspect (2008) 1.28
Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol (2005) 1.28
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res (2008) 1.27
Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control (2003) 1.26
Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet (2006) 1.24
Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev (2008) 1.23
Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol (2008) 1.23
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res (2009) 1.22
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer (2007) 1.21
A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst (2005) 1.20
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev (2009) 1.17
PENALIZED VARIABLE SELECTION PROCEDURE FOR COX MODELS WITH SEMIPARAMETRIC RELATIVE RISK. Ann Stat (2010) 1.16
A global assessment of chromium pollution using sperm whales (Physeter macrocephalus) as an indicator species. Chemosphere (2009) 1.16
Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev (2005) 1.15
Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol (2008) 1.14
Plasmonic photocatalysts: harvesting visible light with noble metal nanoparticles. Phys Chem Chem Phys (2012) 1.13
Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res (2009) 1.13
Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. Cancer Epidemiol Biomarkers Prev (2006) 1.13
Time trends in oral clefts in Chinese newborns: data from the Chinese National Birth Defects Monitoring Network. Birth Defects Res A Clin Mol Teratol (2010) 1.10
Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. J Infect Dis (2004) 1.09
Impact of health insurance on health care treatment and cost in Vietnam: a health capability approach to financial protection. Am J Public Health (2012) 1.08
Hexavalent chromium is cytotoxic and genotoxic to the North Atlantic right whale (Eubalaena glacialis) lung and testes fibroblasts. Mutat Res (2007) 1.08
Impact of illness and medical expenditure on household consumptions: a survey in western China. PLoS One (2012) 1.08
A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers Prev (2005) 1.07
Engineering BiOX (X = Cl, Br, I) nanostructures for highly efficient photocatalytic applications. Nanoscale (2014) 1.06
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA. Brief Bioinform (2014) 1.06
Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2004) 1.06
Passive smoking and preterm birth in urban China. Am J Epidemiol (2014) 1.05
Evidence of the existence of magnetism in pristine VX₂ monolayers (X = S, Se) and their strain-induced tunable magnetic properties. ACS Nano (2012) 1.05
Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res (2005) 1.04
Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. Am J Epidemiol (2004) 1.04
Identification of gene-environment interactions in cancer studies using penalization. Genomics (2013) 1.03
Robust two-dimensional topological insulators in methyl-functionalized bismuth, antimony, and lead bilayer films. Nano Lett (2015) 1.03
Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int (2011) 1.03
Identification of cancer genomic markers via integrative sparse boosting. Biostatistics (2011) 1.02
Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis (2007) 1.02
Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival. Am J Hematol (2010) 1.01
The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila) (2010) 1.01
Ag@AgCl: a highly efficient and stable photocatalyst active under visible light. Angew Chem Int Ed Engl (2008) 1.01
Methyl bromide exposure and cancer risk in the Agricultural Health Study. Cancer Causes Control (2012) 1.01